HYBRID EVENT: You can participate in person at Paris, France or Virtually from your home or work.

6th Edition of World Congress on Infectious Diseases

June 24-26, 2024 | Paris, France

June 24 -26, 2024 | Paris, France
Infection 2024


Speaker at Infectious Diseases Conferences - Zucatelli
Instituto Butantan, Brazil
Title : Antiviral activity of different molecules obtained from invertebrates against coronavirus


Introduction: The coronavirus has become known because of the COVID 9 pandemic. Coronaviruses cause epidemics not only in humans, but also in animals of commercial interest such as birds (Infectious bronchitis virus-IBV). This virus has a replication mechanism similar to the human virus, which makes them a good tool for studying the viral replication and antiviral action of substances against the human coronavirus. The search for new antivirals has become an urgent need. Many studies have been carried out with this aim. Among the multiple sources of research for new antivirals, bioprospecting for molecules obtained from arthropods is one of the options.

Objective: In this study, the objective was to identify, compounds with antiviral effect against avian Coronavirus in propolis from Scaptotrigona aff postiça, hemolymph from Lonomia obliqua and mygalin, a substance extracted from spiders.

Methods: The propolis was obtained from a colony of Scaptotrigona aff postica, from Brazil. Lonomia obliqua hemolymph was obtained from wild caterpillars. The isolation and purification of antiviral substances from propolis and caterpillar hemolymph was performed by a Reverse-Phase HPLC DAD-ESI-MS/MS. Purified mygalin was obtained from the tarantula A. gomesiana. The antiviral assay was performed by reducing infectious foci in VERO cells. Cells were treated 1 hour before infection or 1 hour after infection, with 2, 5 and 10% of propolis or hemolymph and its purified or synthetic components. For purified mygalin or it synthetic analogue was used in test 26, 52, 104 and 160 μM. Treated and untreated cells were infected with different amounts of coronavirus (100 to 1000 DCTI50).

Result: Propolis and crude hemolymph reduced avian coronavirus by an average of 256x when used at a concentration of 5% v/v and an average reduction of 8x when 160μM of mygalin was used. Synthetic mygalin (26 uM), reduced viral replication by 16 times and the purified propolis reduced the virus replication an average of 32 times. The antiviral responses of the 3 substances were dose dependent, being 2 times more intense when added 1 hour before cell infection with the virus.


Degree in Pharmacy and Biochemistry from the State University of Londrina (1980). Master's and Phd degree in Microbiology from the University of Sao Paulo. Has three post-doctorates in Biotechnology, Scientific researcher at the Butantan Institute since 1984. Experience in Microbiology, Virology, Biotechnology and Fermentation. Work with: animal and insect cell culture, apoptosis, cellular metabolism. Development of viral vaccines, optimization of processes and development of culture media, microcarriers, bioreactor, production of viral vaccine. Bioprospection of bioactive proteins in hemolymph of caterpillars, propolis and snake venoms. Bioprospection of antiviral, antimicrobial, anti-inflammatory and antitumoral drugs in animal sources. Currently is Director of the Parasitology Laboratory at the Butantan Institute. Has published more than 100 research articles in SCI(E) journals